Clover Health Exits ACO REACH to Accelerate Path to Profitability
FRANKLIN, Tenn., Dec. 01, 2023 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (NASDAQ:CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it has delivered notice to the Centers for Medicare and Medicaid Services (“CMS”) that it will exit the CMS ACO REACH Program at the end of the 2023 performance year. Written notification will also be sent to all participating physicians in accordance with CMS requirements. The decision will have no impact on its ACO REACH beneficiaries, and Clover will continue to fulfill all of its obligations under the ACO REACH Program for the 2023 performance year.
Related news for (CLOV)
- Clover Health Reports Improved Q1 2024 Financial Results and FY 2024 Guidance
- PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent
- Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023
- Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024